Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim–Chester disease

Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim–Chester disease

Zsófia Váradi,1 Rita Bánusz,1 Judit Csomor,2 Krisztián Kállay,3 Edit Varga,1 Gabriella Kertész,1 Monika Csóka1 1Second Department of Pediatrics, 2First Department of Pathology and Experimental Cancer Research, Semmelweis U...

Full description

Bibliographic Details
Main Authors: Váradi Z, Bánusz R, Csomor J, Kállay K, Varga E, Kertész G, Csóka M
Format: Article
Language:English
Published: Dove Medical Press 2017-01-01
Series:OncoTargets and Therapy
Subjects:
vemurafenib
treatment
Erdheim-Chester disease
Langerhans cell histiocytosis
pediatric histiocytic disorders
Online Access:https://www.dovepress.com/effective-braf-inhibitor-vemurafenib-therapy-in-a-2-year-old-patient-w-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/effective-braf-inhibitor-vemurafenib-therapy-in-a-2-year-old-patient-w-peer-reviewed-article-OTT

Similar Items